Apr. 4 at 7:16 PM
$DVLT Yo
$DVLT bulls – ask yourself this: Why the hell would
$SCLX drop
$150 MILLION (BTC-backed, first tranche already closed, second unlocking 264M shares) on Datavault if it wasn't primed to explode? Scilex ain't some bagholder – they're biotech pros with real skin in the game, handing over serious capital + board seats + exclusive licensing for genomic data tokenization (up to
$2.55B milestones!).👇
As of Jan 12, 2026, after significant selling, Scilex held approximately 219,056,954 shares of DVLT.
The effective purchase price of the shares under the investment agreement was
$0.5378 per
Board Control: Scilex has the right to nominate two directors to the Datavault board as long as they maintain beneficial ownership of at least 10%, and one director for owning 5% to 10%.
License Agreement: The companies have a strategic partnership where Datavault granted Scilex a worldwide exclusive license to use its technology for tokenizing and monetizing Real-World Assets (RWA) in the bio s
